3rd Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery

High Throughput Technology for Hit Generation

 Virtual Event    May 31-June 1, 2023

Confirmed speakers

Improved ASMS Affinity Ranking Using Complete Analysis of Target Titration Data

Dr Brett BABIN
GENENTECH, South San Francicsco, United States

MALDI MS-based Cell Assays in Pharmaceutical R&D – a Perspective

Prof. Carsten HOPF
UNIVERSITY OF MANNHEIM, Mannheim, Germany

Deploying Affinity Selection Mass Spectrometry (ASMS) for Rapid and Flexible Hit Confirmation of DNA-Encoded Library (DEL) Screening in Targeted Protein Modulation (TPM)

Dr Daniel MEDINA-CLEGHORN
NURIX THERAPEUTICS, San Francisco, United States

Affinity Selection Mass Spectrometry: Hit Validation Tool and a Promising High Throughput Screening Platform for Drug Targets

Dr Omprakash NACHAM
ABBVIE, North Chicago, United States

Setting up an AS-MS Screening Method in Pharmaceutical Industry

Mr Kai SINERVO
ORION CORPORATION, Espoo, Finland

Continued Development of Acoustic Mist Ionization Mass Spectrometry and Future High Throughput MS Technologies

Dr Jonathan WINGFIELD
ASTRAZENECA, Macclesfield, United Kingdom